Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
2000 1
2001 2
2007 1
2008 1
2009 3
2010 1
2011 2
2012 1
2013 1
2015 1
2017 4
2018 5
2019 6
2020 2
2021 8
2022 8
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.
Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO, Yousuf Al-Nesf MA, Hssain AA, Yassine HM, Bachmann MF, Uddin S, Dermime S. Fernandes Q, et al. Among authors: merhi m. Ann Med. 2022 Dec;54(1):524-540. doi: 10.1080/07853890.2022.2031274. Ann Med. 2022. PMID: 35132910 Free PMC article. Review.
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
Raza A, Khan AQ, Inchakalody VP, Mestiri S, Yoosuf ZSKM, Bedhiafi T, El-Ella DMA, Taib N, Hydrose S, Akbar S, Fernandes Q, Al-Zaidan L, Krishnankutty R, Merhi M, Uddin S, Dermime S. Raza A, et al. Among authors: merhi m. J Exp Clin Cancer Res. 2022 Mar 15;41(1):99. doi: 10.1186/s13046-022-02318-0. J Exp Clin Cancer Res. 2022. PMID: 35292091 Free PMC article. Review.
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
Dagar G, Gupta A, Masoodi T, Nisar S, Merhi M, Hashem S, Chauhan R, Dagar M, Mirza S, Bagga P, Kumar R, Akil ASA, Macha MA, Haris M, Uddin S, Singh M, Bhat AA. Dagar G, et al. Among authors: merhi m. J Transl Med. 2023 Jul 7;21(1):449. doi: 10.1186/s12967-023-04292-3. J Transl Med. 2023. PMID: 37420216 Free PMC article. Review.
Role of HMGB1 and its associated signaling pathways in human malignancies.
Idoudi S, Bedhiafi T, Pedersen S, Elahtem M, Alremawi I, Akhtar S, Dermime S, Merhi M, Uddin S. Idoudi S, et al. Among authors: merhi m. Cell Signal. 2023 Dec;112:110904. doi: 10.1016/j.cellsig.2023.110904. Epub 2023 Sep 25. Cell Signal. 2023. PMID: 37757902 Free article. Review.
Anti-cancer effects of Tranilast: An update.
Osman S, Raza A, Al-Zaidan L, Inchakalody VP, Merhi M, Prabhu KS, Abdelaziz N, Hydrose S, Uddin S, Dermime S. Osman S, et al. Among authors: merhi m. Biomed Pharmacother. 2021 Sep;141:111844. doi: 10.1016/j.biopha.2021.111844. Epub 2021 Jun 24. Biomed Pharmacother. 2021. PMID: 34174504 Free article. Review.
Applications of polydopaminic nanomaterials in mucosal drug delivery.
Bedhiafi T, Idoudi S, Alhams AA, Fernandes Q, Iqbal H, Basineni R, Uddin S, Dermime S, Merhi M, Billa N. Bedhiafi T, et al. Among authors: merhi m. J Control Release. 2023 Jan;353:842-849. doi: 10.1016/j.jconrel.2022.12.037. Epub 2022 Dec 17. J Control Release. 2023. PMID: 36529384 Free article. Review.
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S, Raza A, Mohsin R, Kanbour A, Qadri S, Parray A, Zar Gul AR, Philip A, Vijayakumar S, Merhi M, Hydrose S, Inchakalody VP, Al-Abdulla R, Abualainin W, Sirriya SA, Al-Bozom I, Uddin S, Khan OM, Mohamed Ibrahim MI, Al Homsi U, Dermime S. Akbar S, et al. Among authors: merhi m. Front Immunol. 2023 Jan 18;13:1097117. doi: 10.3389/fimmu.2022.1097117. eCollection 2022. Front Immunol. 2023. PMID: 36741391 Free PMC article.
59 results